Maschalidi Lab

Phagocytosis in Inflammation and Tissue Repair

Maschalidi Lab about

Sophia Maschalidi
Sophia Maschalidi

Group Leader

Send Email

Our goal is to uncover the molecular and cellular mechanisms that govern phagocytosis and to define its role in tissue repair and inflammation.

We aim to map phagocytosis in its native environment by examining the dynamic transcriptomic, interactomic, and epigenomic changes that occur as cells engulf infectious cargo or dying cells—including those undergoing therapy‑induced death in cancer—and within the surrounding tissue.

A central focus of our work is to develop innovative therapeutic strategies that target the phagocytic machinery to improve chronic iflammatory conditions associated with defective phagocytosis, such as diabetes‑related complications, aging and age‑associated diseases, autoimmune disorders and responses to cancer therapy.

By using cutting-edge technologies (single-cell and spatial multi-omics analyses), sophisticated genetic mouse models and microphysiological experimental models for implementing human diseases, we aim to unveil new layers of regulation in both healthy and diseased tissues and to open the door to innovative treatments that restore proper phagocytosis and promote tissue repair.

Maschalidi Lab team

Meet Our Team

Maschalidi Lab Selected Publications